PROSTATE INT - Prostate International
Publications
- 2022
Up- and downgrading in single intermediate-risk positive biopsy core prostate cancer
Hoeh, B., Flammia, R., Hohenhorst, L., Sorce, G., Chierigo, F., Tian, Z., Saad, F., Gallucci, M., Briganti, A., Terrone, C., Shariat, S. F., Graefen, M., Tilki, D., Kluth, L. A., Mandel, P., Chun, F. K. H. & Karakiewicz, P. I., 03.2022, In: PROSTATE INT. 10, 1, p. 21-27 7 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
- 2021
Management and treatment options for patients with de novo and recurrent hormone-sensitive oligometastatic prostate cancer
Preisser, F., Chun, F. K-H., Banek, S., Wenzel, M., Graefen, M., Steuber, T., Tilki, D. & Mandel, P., 09.2021, In: PROSTATE INT. 9, 3, p. 113-118 6 p.Research output: SCORING: Contribution to journal › SCORING: Review article › Research